Gene |
Function |
Hematological phenotype in mice model |
Disorders (hematologicalphenotype) in human |
Key kinases | |||
ATM |
Plays a central role in DDR |
BMF with HSCs depletion |
Ataxia-telangiectasia (defective B cell differentiation, decreased circulating T cells) |
ATR |
Plays a central role in DDR |
Accelerated aging, dwarfism, pancytopenia accumulation of fat in the BM |
Seckel syndrome (pancytopenia) |
Genes in the FA/BRCA pathway | |||
FANCA, FANCB, FANCC, FANCE, FANCF, FANCG/XRCC9, FANCL, FANCT/UBE2T |
Constituting FA core complex to promote FANCD2/I ubiquitination |
Do not spontaneously develop a BMF phenotype, unless there is additional exogenous stress |
FA (BMF) |
FANCD2, FANCI |
Recruitment of downstream nucleases to excise DNA-ICLs |
||
FANCP/SLX4, FANCQ/ERCC4/XPF |
Structure-specific exonucleases |
||
FANCD1/BRCA2, FANCJ/BRIP1, FANCN/PALB2, FANCU/XRCC2, FANCW/RFWD3 |
Repair of DSB by promoting HR |
||
FANCV/REV7/MAD2L2 |
Bypasss the crosslink remnants; and repair of DSB by promoting NHEJ |
||
Genes in DSB repair machinery | |||
DNA-PKcs/PRKDC |
Serine/threonine-protein kinase that recruit interacts with LIG4-XRCC4 complex to promote DSB end ligation, and essential for V(D)J recombination |
BMF with HSCs depletion |
Severe combined immunodeficiency (decreased circulating T and B cells) |
LIG4 |
ATP-dependent DNA ligase that interacts with XRCC4 to promote DSB end ligation, and essential for V(D)J recombination |
Immunodeficiency, BMF with HSCs depletion |
LIG4 syndrome (pancytopenia) |
NBS1 |
A member of MRN complex, promotes DSB end resection |
BMF with HSCs depletion |
Nijmegen breakage syndrome (autoimmune hemolytic anemia,thrombocytopenia post hemolytic anemia, decreased circulating T and B cells) |
Genes in MMR pathway | |||
MLH1, MSH2, MSH6, PMS2 |
Repair of mismatches |
Hematopoietic malignancies (leukemia and lymphoma |
Mismatch repair cancer syndrome (leukemia) |
Others | |||
ERCC6L2 |
May play a role in the NER pathway |
None |
BMF syndrome |
ADH5 and ALDH2 (Digenic) |
Detoxifying enzymes that metabolize formaldehyde and acetaldehyde, respectively |
Depletion of LT-HSCs and CLPs |
AMED syndrome (BMF) |
BM, bone marrow; BMF, bone marrow failure; CLPs, lymphoid progenitor; DDR, DNA damage response; DNA-ICLs, DNA inter-strand crosslinks; DSB, double-strand break; FA, Fanconi anemia; LT-HSCs, long-term hematopoietic stem cells; MMR, mismatch repair; MRN, MRE11-RAD50-NBS1; NER, nucleotide excision repair; NHEJ, non-homologous end joining; HR, homologous recombination; REF, reference